Guidelines from the American Society of Clinical Oncology discourage the use of CA 19-9 as a screening test for cancer, particularly pancreatic cancer.
In people with pancreatic masses, CA 19-9 can be useful in distinguishing between cancer and other diseases of the gland [REF].